References
- Altman R, Asch E, Bloch D, et al. (1986). Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–49
- Antonsson B, Martinou JC. (2000). The Bcl-2 protein family. Exp Cell Res 256:50–7
- Arnett FC, Edworthy SM, Bloch DA, et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24
- Burow ME, Weldon CB, Melnik LI, et al. (2000). PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem Biophys Res Commun 271:342–5
- Cheng AX, Lou SQ, Zhou HW, et al. (2004). Expression of PDCD5, a novel apoptosis related protein, in human osteoarthritic cartilage. Acta Pharmacol Sin 25:685–90
- Feldmann M, Brennan FM, Maini RN. (1996). Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440
- Hedenfalk I, Duggan D, Chen Y, et al. (2001). Gene-expression profiles in hereditary breast cancer. N Engl J Med 344:539–48
- Irmler M, Thome M, Hahne M, et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388:190–5
- Kim KN, Watanabe S, Ma Y, et al. (2000). Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer. J Immunol 164:1576–81
- Kobayashi T, Okamoto K, Kobata T, et al. (1999). Tumor necrosis factor alpha regulation of the FAS mediated apoptosis-signaling pathway in synovial cells. Arthritis Rheum 42:519–26
- Liu H, Wang Y, Zhang Y, et al. (1999). TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254:203–10
- Ma X, Ruan G, Wang Y, et al. (2005). Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5′ regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population. Clin Cancer Res 11:8592–9
- Mallya RK, de Beer FC, Berry H, et al. (1982). Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 9:224–8
- Perlman H, Georganas C, Pagliari LJ, et al. (2000). Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 164:5227–35
- Perlman H, Liu H, Georganas C, et al. (2001). Differential expression pattern of the antiapoptotic proteins, Bcl-2 and FLIP, in experimental arthritis. Arthritis Rheum 44:2899–908
- Pope RM. (2002). Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2:527–35
- Schneider G, Henrich A, Greiner G, et al. (2010). Cross talk between stimulated NF-kappaB and the tumor suppressor p53. Oncogene 29:2795–806
- Seemayer CA, Kuchen S, Neidhart M, et al. (2003). p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion. Ann Rheum Dis 62:1139–44
- Wang N, Lu HS, Guan ZP, et al. (2007). Involvement of PDCD5 in the regulation of apoptosis in fibroblast-like synoviocytes of rheumatoid arthritis. Apoptosis 12:1433–41
- Xu L, Hu J, Zhao Y, et al. (2012). PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway. Apoptosis 17:1235–45
- Xu XR, Huang J, Xu ZG, et al. (2001). Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98:15089–94